Triamcinolone Acetonide Shows No Direct Toxicity to Human Knee Cartilage

Intra-articular corticosteroid injections remain a cornerstone of symptomatic management for knee osteoarthritis, particularly when inflammatory synovitis or acute pain flares limit patient mobility [1]. While these agents provide rapid analgesic effects, their long-term impact on joint health remains a subject of intense clinical debate [2]. Many practitioners balance the immediate benefits of pain reduction against reports suggesting that repeated steroid exposure may accelerate the progression of cartilage loss [3]. Current professional guidelines reflect this uncertainty, offering inconsistent recommendations that vary significantly across different medical societies [1]. Recent comparative trials have sought to weigh the efficacy of corticosteroids against biological alternatives or different delivery methods to minimize potential structural harm [4, 5]. A new study using human cartilage models now offers a detailed metabolic analysis to clarify whether these medications are directly responsible for joint degradation.